Date published: 2026-4-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

V2R Activators

V2R activators are a group of compounds that either directly activate the V2R receptor or modulate its activity through indirect mechanisms, leading to enhanced functional responses in water reabsorption and regulation in the kidneys. Direct activators, such as Desmopressin and Arginine Vasopressin, bind to V2R, mimicking the natural ligand's effect, thereby triggering the receptor's intrinsic signaling cascade. This activation leads to increased water reabsorption in the kidney's collecting ducts, a critical process in maintaining the body's fluid balance. These activators demonstrate the receptor's responsiveness to synthetic analogs and natural ligands, elucidating the receptor's role in physiological antidiuretic responses. On the other hand, several V2R antagonists, including Lixivaptan, Tolvaptan, and Satavaptan, play a unique role in modulating the receptor's activity. While these compounds initially inhibit the receptor's function by preventing vasopressin binding, chronic exposure to these antagonists can lead to compensatory responses in the body, such as upregulation of the receptor and increased sensitivity. This adaptation can enhance the receptor's activity upon subsequent exposure to its natural ligand.

The indirect activators, encompassing various V2R antagonists like Mozavaptan, Conivaptan, and non-peptide V2R antagonists, demonstrate a different mechanism of enhancing V2R's functional activity. By competitively binding to the receptor, these antagonists prevent the immediate response typically induced by vasopressin. However, this inhibition is met with a cellular compensatory mechanism, where the receptor's expression levels and sensitivity are increased. This increased expression and sensitivity mean that upon binding of vasopressin, the receptor exhibits a heightened response, thus enhancing its functional activity. Such mechanisms highlight the dynamic nature of receptor regulation in the body, where inhibition can paradoxically lead to an enhanced response through cellular adaptation processes. This complex interplay between direct and indirect activators of V2R underscores the multifaceted approaches that can be used to modulate receptor activity, reflecting the intricacies of receptor-ligand interactions and their implications in physiological regulation.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Desmopressin

16679-58-6sc-391126
1 mg
$138.00
(0)

Desmopressin is a synthetic analog of vasopressin. It binds to and activates V2R, leading to enhanced water reabsorption in the kidneys.

Arginine vasopressin

113-79-1sc-507381
100 mg
$810.00
(0)

Arginine Vasopressin, the natural ligand of V2R, binds and activates the receptor, enhancing its functional activity in water reabsorption.

Lixivaptan

168079-32-1sc-489378
5 mg
$84.00
(0)

Lixivaptan is a V2R antagonist. Its competitive binding can lead to upregulation and increased sensitivity of V2R as a compensatory mechanism.

Tolvaptan

150683-30-0sc-364638
sc-364638A
10 mg
50 mg
$125.00
$624.00
(0)

Tolvaptan, another V2R antagonist, functions similarly to Lixivaptan. It can potentially enhance V2R activity through receptor upregulation.

Mozavaptan Hydrochloride

138470-70-9sc-358376
sc-358376A
10 mg
100 mg
$64.00
$259.00
2
(1)

Mozavaptan, a V2R antagonist, can potentially lead to enhanced V2R activity through receptor upregulation and increased sensitivity.

SR 49059

150375-75-0sc-204300
10 mg
$354.00
(1)

Also called Relcovaptan, this compound is a selective V2R antagonist, may enhance V2R activity by increasing receptor expression and sensitivity.